Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7321
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    83.76
    +0.19 (+0.23%)
     
  • Bitcoin CAD

    88,103.67
    +356.82 (+0.41%)
     
  • CMC Crypto 200

    1,390.84
    +8.27 (+0.60%)
     
  • GOLD FUTURES

    2,344.10
    +1.60 (+0.07%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,754.75
    +187.25 (+1.07%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Canada Goose Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Canada Goose Holdings, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 2, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Canada Goose Holdings, Inc. (NYSE: GOOS) ("Canada Goose" or the "Company").



Faruqi & Faruqi Logo

If you invested in Canada Goose stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/GOOS. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

ADVERTISEMENT

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49359